Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.16%. Meanwhile, the Dow lost 0.12%, and the Nasdaq, a tech-heavy index, lost 0.33%.

Coming into today, shares of the company had gained 6.53% in the past month. In that same time, the Medical sector lost 8.16%, while the S&P 500 lost 10.5%.

TEVA will be looking to display strength as it nears its next earnings release. In that report, analysts expect TEVA to post earnings of $0.58 per share. This would mark a year-over-year decline of 3.33%. Meanwhile, our latest consensus estimate is calling for revenue of $4.13 billion, down 3.84% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $2.44 per share and revenue of $16.67 billion. These totals would mark changes of +1.67% and -3.97%, respectively, from last year.

Investors might also notice recent changes to analyst estimates for TEVA. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.97% lower within the past month. TEVA is holding a Zacks Rank of #3 (Hold) right now.

Looking at its valuation, TEVA is holding a Forward P/E ratio of 3.88. Its industry sports an average Forward P/E of 5.84, so we one might conclude that TEVA is trading at a discount comparatively.

Home of Science
Follow me

- Advertisement -

Discover

Sponsor

Latest

Mesothelioma Causes – Discover the Mesothelioma Causes

Mesothelioma Causes - Discover the Mesothelioma CausesThe causes of mesothelioma are unknown, but it is considered to be the most lethal form of...

Is Instagram Affecting Your Business?

One of the hottest trends to hit the social networking scene lately is the use of Instagram. There are thousands of people who use...

Coronavirus erases almost all the 23 million new jobs created since the Great Recession

It took 10 years for the U.S. economy to create 23 million new jobs. It took the coronavirus pandemic just a month to destroy...

Priyank Chopra

Priyank ChopraPriyank Chopra has a remarkable reputation for sharing his wisdom with the world. He is regarded as one of the foremost authorities...

Austin-Based Living Security Secures $5M To Make Cybersecurity Training More Fun

Existing backer Active Capital and new investors Rain Capital and SaaS Venture Partners also participated in the financing. Husband and wife Drew and Ashley Rose founded the company in June 2017 out of their home...
Home of Science
Follow me